APA citiranje

Toyoda, Y., Takada, T., Umezawa, M., Tomura, F., Yamanashi, Y., Takeda, K., & Suzuki, H. (2019). Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe‐mediated steatosis prevention and recovery. FASEB Bioadv.

Citação norma Chicago

Toyoda, Yu, Tappei Takada, Masakazu Umezawa, Fumiya Tomura, Yoshihide Yamanashi, Ken Takeda, and Hiroshi Suzuki. "Identification of Hepatic NPC1L1 As an NAFLD Risk Factor Evidenced By Ezetimibe‐mediated Steatosis Prevention and Recovery." FASEB Bioadv 2019.

MLA citiranje

Toyoda, Yu, et al. "Identification of Hepatic NPC1L1 As an NAFLD Risk Factor Evidenced By Ezetimibe‐mediated Steatosis Prevention and Recovery." FASEB Bioadv 2019.